Theralase Technologies Inc. (TLTFF)

Theralase Technologies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	35	46	30	51	61	30
Market Cap Growth	14.80%	50.74%	-40.86%	-15.43%	98.73%	-43.12%
Enterprise Value	35	46	30	50	57	24
Last Close Price	0.14	0.18	0.14	0.25	0.29	0.15
PS Ratio	53.14	63.54	37.35	60.85	98.13	41.77
PB Ratio	46.26	31.76	20.98	22.40	15.11	4.24
P/TBV Ratio	46.26	31.76	20.98	22.40	15.11	4.24
EV/Sales Ratio	50.93	63.53	37.52	59.13	91.82	32.43
Debt / Equity Ratio	0.25	0.14	0.20	0.15	0.01	0.01
Asset Turnover	0.31	0.32	0.29	0.23	0.10	0.07
Inventory Turnover	0.78	0.80	0.89	0.97	0.92	1.17
Quick Ratio	0.47	0.99	0.60	2.86	4.56	10.18
Current Ratio	0.82	1.61	1.39	3.67	5.71	10.85
Return on Equity (ROE)	-291.49%	-214.26%	-182.91%	-128.27%	-61.98%	-48.64%
Return on Assets (ROA)	-90.70%	-82.17%	-77.21%	-64.71%	-35.56%	-28.06%
Return on Capital (ROIC)	-152.34%	-115.19%	-98.02%	-75.41%	-39.53%	-30.76%
Earnings Yield	-8.84%	-6.48%	-11.43%	-7.56%	-5.76%	-14.42%
FCF Yield	-5.28%	-5.10%	-10.28%	-7.47%	-5.39%	-11.88%
Buyback Yield / Dilution	-9.61%	-9.14%	-5.79%	-1.79%	-	-41.19%

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.